MTHFR gene polymorphism as an exacerbation factor of diabetic nephropathy in type 2 diabetes: Analysis in japanese male hemodialysis patients [7]

Diabetes Care

Volumn 23, Issue 2, 2000, Pages 260-

  Noiri, Eisei ^a,b   Taguchi, Jun Ichi ^a   Nakao, Akihide ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HOMOCYSTEINE; METHYLENETETRAHYDROFOLIC ACID;

ADULT; AGED; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE SEVERITY; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK FACTOR;

EID: 0342545889     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.2.260b     Document Type: Letter

References (5)

1. Frosst T, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJH, den Heijer M, Kluijtmans LAJ, van den Heuvel LP, Rozen R: A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111-113, 1995
2. Födinger M, Mannhalter C, Wölfl G, Pabinger I, Müller E, Schmid R, Hörl WH, Sunder-Plassmann G: Mutation in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients. Kidney Int 52:517-523, 1997
3. Morita H, Taguchi J, Kurihara H, Kitaoka M, Kaneda H, Kurihara Y, Maemura K, Shindo T, Minamino T, Ohno M, Yamaoki K, Ogasawara K, Aizawa T, Suzuki S, Yazaki Y: Genetic polymorphism of 5,10-methylenetetrahydrofolate reductase (MTHFR) as a risk factor for coronary artery disease. Circulation 95:2032-2036, 1997
4. Neugebauer S, Baba T, Watanabe T: Methylenetetrahydrofolate reductase gene polymorphism as a risk factor for diabetic nephropathy in NIDDM patients. Lancet 352:454, 1998
5. Smyth JS, Savage DA, Maxwell AP: MTHFR gene polymorphism and diabetic nephropathy in type 1 diabetes. Lancet 353:1156, 1999